Investors on Wall Street are turning to high-tax biotech stocks as a safe haven amid concerns over tariffs. This shift highlights the evolving strategies in financial markets to mitigate risks associated with global trade tensions.
— new from WSJ
Investors on Wall Street are turning to high-tax biotech stocks as a safe haven amid concerns over tariffs. This shift highlights the evolving strategies in financial markets to mitigate risks associated with global trade tensions.
— new from WSJ